T. Sirisinha
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
-
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 5
- Cancer survivorship and care 3
-
- Palliative Care and End-of-Life Issues 3
- Co-authors
- Ekaphop Sirachainan (3 shared papers)V. Ratanatharathorn (3 shared papers)Touch Ativitavas (4 shared papers)Ravat Panvichian (3 shared papers)Wasun Chantratita (1 shared paper)Monpat Chamnanphon (1 shared paper)Virote Sriuranpong (1 shared paper)Tony Mok (1 shared paper)
In The Last Decade
T. Sirisinha
9 papers receiving 174 citations
Peers
Comparison fields: 5 of 39
- Pharmacology 42
- Oncology 76
- Family Practice 2
- Pulmonary and Respiratory Medicine 28
- Geriatrics and Gerontology 3
Countries citing papers authored by T. Sirisinha
This map shows the geographic impact of T. Sirisinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Sirisinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Sirisinha more than expected).
Fields of papers citing papers by T. Sirisinha
This network shows the impact of papers produced by T. Sirisinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Sirisinha. The network helps show where T. Sirisinha may publish in the future.
Co-authors
The 18 scholars most cited alongside T. Sirisinha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 43 | |
| 2 | 2011 | 37 | |
| 3 | 2012 | 35 | |
| 4 | 2012 | 27 | |
| 5 | Quality of life, Functional Assessment of Cancer Therapy-General. | 2001 | 24 |
| 6 | 2011 | 4 | |
| 7 | Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital. | 2010 | 3 |
| 8 | The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version. | 2002 | 2 |
| 9 | 2006 | 1 |
About T. Sirisinha
T. Sirisinha is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Pharmacology, Pulmonary and Respiratory Medicine and Economics and Econometrics, having authored 9 papers that have together received 176 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Palliative Care and End-of-Life Issues (3 papers), Cancer survivorship and care (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Lung Cancer Treatments and Mutations (2 papers), Estrogen and related hormone effects (1 paper), Head and Neck Cancer Studies (1 paper) and Childhood Cancer Survivors' Quality of Life (1 paper). The work is most often cited by research in Pharmacology (42 citations), Oncology (76 citations), Family Practice (2 citations), Pulmonary and Respiratory Medicine (28 citations) and Geriatrics and Gerontology (3 citations). T. Sirisinha has collaborated with scholars based in Thailand, Hong Kong and China. Frequent co-authors include Ekaphop Sirachainan, V. Ratanatharathorn, Touch Ativitavas, Ravat Panvichian, Wasun Chantratita, Monpat Chamnanphon, Virote Sriuranpong, Tony Mok, Christian Manegold and N. Moore. Their work appears in journals such as Journal of Clinical Oncology, Quality of Life Research, Pharmacogenomics and Personalized Medicine, Asian Pacific Journal of Cancer Prevention and Asia-Pacific Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.